# No Tile Left Behind: Multiprogramming for Surface-Code Architectures

Preprint · Archisman Ghosh, Avimita Chatterjee, Swaroop Ghosh

- Archive id: arxiv:2604.25976
- Published: 2026-04-28
- arXiv: <https://arxiv.org/abs/2604.25976>
- Source URL: <https://arxiv.org/abs/2604.25976>
- PDF: <https://arxiv.org/pdf/2604.25976>
- Provenance: arxiv

## Abstract

Fault-tolerant quantum computing (FTQC) is emerging as the architectural regime in which practical large-scale quantum workloads will execute. In this setting, however, multiprogramming is no longer a matter of partitioning a flat pool of qubits. Quantum error correction exposes a structured floorplan of data tiles, ancilla tiles, and magic-state service resources, so concurrent execution must account for compact placement, connectivity, routing headroom, and shared support infrastructure. This makes FTQC multiprogramming fundamentally harder than its NISQ counterpart: admission decisions can fragment the remaining floorplan, conservative reservations can waste ancilla, and dynamic contention across data, ancilla, and magic-state resources can degrade both throughput and quality of service. In this work, we develop a formal framework for FTQC multiprogramming that captures these structural constraints and their runtime implications. We formulate the baseline static allocation problem, extend it to limited-resource and online settings through hierarchy-aware scheduling policies, and further generalize it to cultivation-enabled architectures with dynamic magic-state generation. Through simulation on synthetic Clifford+T workloads, the proposed scheduler achieves a normalized system speedup of 3.1x, improving over prior FTQC multiprogramming baselines by \~29% while maintaining low mean slowdown.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._


---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
